Elective volumes in common Head and Neck cancers-identifying nodal and non-nodal volumes at risk-AM2018
In this session, we will discuss common Head and Neck cancer presentations treated with definitive/post operative radiation. We will discuss coverage of specific nodal volumes based on evidence and published guidelines. We will also discuss coverage of non-nodal regions at risk related to the primary cancer. Contours demonstrating these concepts will be discussed with attention to maximizing coverage and minimizing normal tissue toxicity. We will discuss the future course of nodal coverage with regards to upcoming clinical trials particularly focused on low risk HPV related oropharynx cancer.
This activity is available from January 17, 2019, through 11:59 p.m. Eastern time on January 16, 2022.
This activity was originally recorded at ASTRO’s 2018 Annual Meeting, October 22-24, 2018 in San Antonio, TX.
The meeting is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, radiation physicists, radiation therapists, residents, and specialists.
- Describe standard nodal regions at risk for common Head and Neck cancer presentations.
- Describe standard non-nodal elective coverage around the primary lesion.
- Jimmy Caudell, MD, PhD is employed by the Moffitt Cancer Center and receives compensation/remuneration/funding from Proknow Systems.
- Nikhil Joshi, MD is employed by the Cleveland Clinic Foundation and University Hospitals and has nothing to disclose.
- Matthew Witek, MD, MS is employed by the University of Wisconsin and receives compensation/remuneration/funding from Accuray.
Additionally, the SA-CME Task Force and the CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.